These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 581490)

  • 21. ASHP national survey of hospital-based pharmaceutical services--1990.
    Crawford SY
    Am J Hosp Pharm; 1990 Dec; 47(12):2665-95. PubMed ID: 2278284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A practical approach enabling staff pharmacists to prospectively review and dose aminoglycoside therapy.
    Possidente CJ; Lynch T
    Hosp Pharm; 1988 Nov; 23(11):976-8, 981-3. PubMed ID: 10290757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidisciplinary program for detecting and evaluating adverse drug reactions.
    Keith MR; Bellanger-McCleery RA; Fuchs JE
    Am J Hosp Pharm; 1989 Sep; 46(9):1809-12. PubMed ID: 2801715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug newsletters and quality assurance of drug usage.
    Plumridge RJ; Greenhill GT; Blackbourn J
    Hosp Pharm; 1988 Aug; 23(8):718, 720-4, 729. PubMed ID: 10288921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of electronic data processing for drug utilization review.
    Mehl B
    QRB Qual Rev Bull; 1979 Jan; 5(1):13-6. PubMed ID: 121374
    [No Abstract]   [Full Text] [Related]  

  • 27. Need we revive falling autopsy rates? Time trends in PAS hospitals in the United States.
    Lowe JA; Davis CJ
    PAS Rep; 1977 Dec; 15(12):1-7. PubMed ID: 10307292
    [No Abstract]   [Full Text] [Related]  

  • 28. On the use of narrow age ranges in setting review dates for pediatric patients.
    Ament RP
    PAS Rep; 1978 Mar; 16(3):33-9. PubMed ID: 10308496
    [No Abstract]   [Full Text] [Related]  

  • 29. Physician-, nurse-, and pharmacist-conducted patient drug histories.
    Walchle RD; McKercher PL; Cooper JW
    Contemp Pharm Pract; 1980; 3(2):75-8. PubMed ID: 10246110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A blueprint for antibiotic utilization review.
    Leist ER
    Hosp Med Staff; 1981 May; 10(5):19-24. PubMed ID: 10251098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modification of physician behavior by performance feedback.
    Corder MP
    Physician Exec; 1996 Apr; 22(4):26-8. PubMed ID: 10156726
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical pharmacist in a multidisciplinary team in a paediatric department].
    Kjeldby C; Bjerre A; Refsum N
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1746-9. PubMed ID: 19756055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive drug-use evaluation program in a health maintenance organization.
    Cotterell CC; Dombroske L; Fischermann EA
    Am J Hosp Pharm; 1991 Aug; 48(8):1712-7. PubMed ID: 1897551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality assurance: the cost of utilization review and the educational value of medical audit in a university hospital.
    McSherry CK
    Surgery; 1976 Jul; 80(1):122-9. PubMed ID: 1273761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality Assurance Program: AHA's attempt to keep the medical review function in the hospital.
    Mod Hosp; 1973 Mar; 120(3):40-1. PubMed ID: 4798717
    [No Abstract]   [Full Text] [Related]  

  • 36. One way to monitor antibiotic usage.
    Geshan AE
    Hosp Med Staff; 1977 Sep; 6(9):20-3. PubMed ID: 10305362
    [No Abstract]   [Full Text] [Related]  

  • 37. PASport. Use of Professional Activity Study (PAS) data to focus medical care evaluation studies.
    Lowe JA
    QRB Qual Rev Bull; 1977 Aug; 3(8):20-3, 31. PubMed ID: 411085
    [No Abstract]   [Full Text] [Related]  

  • 38. Initiation of a clinical pharmacology consult service as a formulary management tool.
    Albertson T; Musallam N; Tharratt S; Romac D; Foulke G; Mowers R; Panecek E
    Hosp Formul; 1993 Aug; 28(8):699-702, 707. PubMed ID: 10127748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and application of criteria in drug use review programs.
    Knapp DA; Knapp DE; Brandon BM; West S
    Am J Hosp Pharm; 1974 Jul; 31(7):648-56. PubMed ID: 4859271
    [No Abstract]   [Full Text] [Related]  

  • 40. Organizing for utilization review.
    Newmark GL
    Hospitals; 1975 Mar; 49(6):22. PubMed ID: 1167842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.